News
The US Food and Drug Administration (FDA) has approved Nuvation Bio’s Ibtrozi (taletrectinib) to treat adults with a rare and ...
These are the first clinical study results for the drug in a large population of patients with darker skin tones ...
That is why global cooperation is so crucial to rare disease research. National, international and community partnerships and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results